Andrew Workman
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 12
- SARS-CoV-2 and COVID-19 Research 3
-
- Long-Term Effects of COVID-19 2
- Journals
- The Lancet Respiratory Medicine (3 papers)Open Forum Infectious Diseases (2 papers)The Lancet (1 paper)Science Immunology (1 paper)Nature Communications (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Andrew Workman
20 papers receiving 2.7k citations
Andrew Workman's Hit Papers
Peers
Comparison fields: 5 of 113
- Infectious Diseases 1.8k
- Applied Microbiology and Biotechnology 77
- Neurology 197
- Genetics 326
- Modeling and Simulation 45
Countries citing papers authored by Andrew Workman
This map shows the geographic impact of Andrew Workman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Workman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Workman more than expected).
Fields of papers citing papers by Andrew Workman
This network shows the impact of papers produced by Andrew Workman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Workman. The network helps show where Andrew Workman may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Hit paper breakdown → | 2022 | 746 |
| 2 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 3 | 2021 | 256 | |
| 4 | 2021 | 172 | |
| 5 | 2021 | 161 | |
| 6 | 2021 | 138 | |
| 7 | 2021 | 121 | |
| 8 | 2022 | 87 | |
| 9 | 2021 | 81 | |
| 10 | 2021 | 70 | |
| 11 | Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Hit paper breakdown → | 2024 | 65 |
| 12 | 2021 | 51 | |
| 13 | 2023 | 32 | |
| 14 | 2023 | 24 | |
| 15 | 2023 | 24 | |
| 16 | 2021 | 21 | |
| 17 | 2022 | 16 | |
| 18 | 2022 | 12 | |
| 19 | 2023 | 6 | |
| 20 | 2022 | 3 |
About Andrew Workman
Andrew Workman is a scholar working on Infectious Diseases, Neurology, Emergency Medical Services, Genetics and Nephrology, having authored 21 papers that have together received 2.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (12 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Genetic Associations and Epidemiology (2 papers), Long-Term Effects of COVID-19 (2 papers), COVID-19 and healthcare impacts (1 paper), Sepsis Diagnosis and Treatment (1 paper), Acute Kidney Injury Research (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Infectious Diseases (1.8k citations), Applied Microbiology and Biotechnology (77 citations), Neurology (197 citations), Genetics (326 citations) and Modeling and Simulation (45 citations). Andrew Workman has collaborated with scholars based in United Kingdom. Their work appears in journals such as The Lancet Respiratory Medicine, Open Forum Infectious Diseases, The Lancet, Science Immunology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.